Richard R M Goldberg

40PUBLICATIONS
208CO-AUTHORS
Molecular targetsNorth American historyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Jul 11, 2026
Genomic analysis of oesophageal carcinoma (EC) identifies recurrent mutations in histone methyltransferases as a distinctive subset.

|Jul 10, 2026
Activation of the endocytosis pathway stratifies subtypes and therapeutic sensitivity in colorectal cancer.

|Jun 09, 2025
Birth Cohort Effects in Appendiceal Adenocarcinoma Incidence Across the United States.

Andreana N Holowatyj, Mary K Washington, Richard M Goldberg

|May 05, 2025
Characteristics of Patients and Prognostic Factors Across Treatment Lines in Metastatic Colorectal Cancer: An Analysis From the Aide et Recherche en Cancérologie Digestive Database.

Jean-Baptiste Bachet, Aimery de Gramont, Morteza Raeisi

|Sep 04, 2024
Assessment of the Addition of Oxaliplatin to Fluoropyrimidine-Based Adjuvant Chemotherapy in Patients With High-Risk Stage II Colon Cancer: An ACCENT Pooled Analysis.

Benoist Chibaudel, Morteza Raeisi, Romain Cohen

|Mar 28, 2024
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials.

Claire Gallois, Qian Shi, Levi D Pederson

Pageof 7

Frequent Collaborators

15 joint publications

Qian Shi

11 joint publications

Anthony Frank Shields

10 joint publications

Heinz-Josef Lenz

8 joint publications

Thierry André